Literature DB >> 24957145

Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.

Thorbjørn Krejsgaard1, Andreas Willerslev-Olsen1, Lise M Lindahl2, Charlotte M Bonefeld1, Sergei B Koralov3, Carsten Geisler1, Mariusz A Wasik4, Robert Gniadecki5, Mogens Kilian6, Lars Iversen2, Anders Woetmann1, Niels Odum1.   

Abstract

Patients with cutaneous T-cell lymphoma (CTCL) are frequently colonized with Staphylococcus aureus (SA). Eradication of SA is, importantly, associated with significant clinical improvement, suggesting that SA promotes the disease activity, but the underlying mechanisms remain poorly characterized. Here, we show that SA isolates from involved skin express staphylococcal enterotoxins (SEs) that induce crosstalk between malignant and benign T cells leading to Stat3-mediated interleukin-10 (IL-10) production by the malignant T cells. The SEs did not stimulate the malignant T cells directly. Instead, SEs triggered a cascade of events involving cell-cell and asymmetric cytokine interactions between malignant and benign T cells, which stimulated the malignant T cells to express high levels of IL-10. Much evidence supports that malignant activation of the Stat3/IL-10 axis plays a key role in driving the immune dysregulation and severe immunodeficiency that characteristically develops in CTCL patients. The present findings thereby establish a novel link between SEs and immune dysregulation in CTCL, strengthening the rationale for antibiotic treatment of colonized patients with severe or progressive disease.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24957145      PMCID: PMC4118485          DOI: 10.1182/blood-2014-01-551184

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  70 in total

1.  Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.

Authors:  Q Zhang; P N Raghunath; E Vonderheid; N Odum; M A Wasik
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

2.  Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.

Authors:  C Brender; P Lovato; V H Sommer; A Woetmann; A-M Mathiesen; C Geisler; M Wasik; N Ødum
Journal:  Leukemia       Date:  2005-02       Impact factor: 11.528

3.  Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins.

Authors:  Y Tokura; P W Heald; S L Yan; R L Edelson
Journal:  J Invest Dermatol       Date:  1992-01       Impact factor: 8.551

4.  CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas Ligand, and killing inhibitory receptors and their relationship with clinical behavior.

Authors:  M H Vermeer; R van Doorn; D Dukers; M W Bekkenk; C J Meijer; R Willemze
Journal:  J Clin Oncol       Date:  2001-12-01       Impact factor: 44.544

5.  Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines.

Authors:  Maria Wysocka; Mohamed H Zaki; Lars E French; Jihed Chehimi; Michael Shapiro; Suzanne E Everetts; Karen S McGinnis; Luis Montaner; Alain H Rook
Journal:  Blood       Date:  2002-11-01       Impact factor: 22.113

6.  Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis.

Authors:  Remco van Doorn; Remco Dijkman; Maarten H Vermeer; Jacoba J Out-Luiting; Elisabeth M H van der Raaij-Helmer; Rein Willemze; Cornelis P Tensen
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

7.  Polyclonal expansion of T cells with the TCR V beta type of the tumour cell in lesions of cutaneous T-cell lymphoma: evidence for possible superantigen involvement.

Authors:  T Linnemann; S Gellrich; A Lukowsky; A Mielke; H Audring; W Sterry; P Walden
Journal:  Br J Dermatol       Date:  2004-05       Impact factor: 9.302

8.  In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3.

Authors:  V H Sommer; O J Clemmensen; O Nielsen; M Wasik; P Lovato; C Brender; K W Eriksen; A Woetmann; C G Kaestel; M H Nissen; C Ropke; S Skov; N Ødum
Journal:  Leukemia       Date:  2004-07       Impact factor: 11.528

9.  A continuous T-cell line from a patient with Sézary syndrome.

Authors:  K Kaltoft; S Bisballe; H F Rasmussen; K Thestrup-Pedersen; K Thomsen; W Sterry
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

10.  Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas.

Authors:  Reinhard Dummer; Jessica C Hassel; Friederike Fellenberg; Stefan Eichmüller; Tanja Maier; Philippe Slos; Bruce Acres; Pascal Bleuzen; Vincent Bataille; Patrick Squiban; Günter Burg; Mirjana Urosevic
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  25 in total

Review 1.  [Treatment of mycosis fungoides and Sézary syndrome].

Authors:  J P Nicolay; C Assaf
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

2.  Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.

Authors:  Melania H Fanok; Amy Sun; Laura K Fogli; Vijay Narendran; Miriam Eckstein; Kasthuri Kannan; Igor Dolgalev; Charalampos Lazaris; Adriana Heguy; Mary E Laird; Mark S Sundrud; Cynthia Liu; Jeff Kutok; Rodrigo S Lacruz; Jo-Ann Latkowski; Iannis Aifantis; Niels Ødum; Kenneth B Hymes; Swati Goel; Sergei B Koralov
Journal:  J Invest Dermatol       Date:  2017-11-08       Impact factor: 8.551

Review 3.  Mycosis Fungoides and Sézary Syndrome: An Update.

Authors:  Cecilia Larocca; Thomas Kupper
Journal:  Hematol Oncol Clin North Am       Date:  2019-02       Impact factor: 3.722

4.  Toxic effects of seu are different from those of other staphylococcal enterotoxins.

Authors:  Yi Li; Hui Deng; Pei-Dian Shi; Dan-Dan Xu; Li-Lin Zhang; Lei Zhang; Jin-Hai Huang
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

5.  Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.

Authors:  Lise M Lindahl; Andreas Willerslev-Olsen; Lise M R Gjerdrum; Pia R Nielsen; Edda Blümel; Anne H Rittig; Pamela Celis; Bjorn Herpers; Jürgen C Becker; Birgitte Stausbøl-Grøn; Mariusz A Wasik; Maria Gluud; Simon Fredholm; Terkild B Buus; Claus Johansen; Claudia Nastasi; Lukas Peiffer; Linda Kubat; Michael Bzorek; Jens O Eriksen; Thorbjørn Krejsgaard; Charlotte M Bonefeld; Carsten Geisler; Tomas Mustelin; Erik Langhoff; Michael Givskov; Anders Woetmann; Mogens Kilian; Thomas Litman; Lars Iversen; Niels Odum
Journal:  Blood       Date:  2019-07-22       Impact factor: 22.113

6.  Photodynamic therapy controls of Staphylococcus aureus intradermal infection in mice.

Authors:  Palloma Porto Almeida; Ítalo Sousa Pereira; Karine Bitencourt Rodrigues; Lorena Santos Leal; Andressa Souza Marques; Luciano Pereira Rosa; Francine Cristina da Silva; Robson Amaro Augusto da Silva
Journal:  Lasers Med Sci       Date:  2017-06-23       Impact factor: 3.161

7.  High Expression of IKZF2 in Malignant T Cells Promotes Disease Progression in Cutaneous T Cell Lymphoma.

Authors:  Bufang Xu; Fengjie Liu; Yumei Gao; Jingru Sun; Yingyi Li; Yuchieh Lin; Xiangjun Liu; Yujie Wen; Shengguo Yi; Jingyang Dang; Ping Tu; Yang Wang
Journal:  Acta Derm Venereol       Date:  2021-12-07       Impact factor: 3.875

8.  Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.

Authors:  Alyxzandria M Gaydosik; Connor J Stonesifer; Alexandra E Khaleel; Larisa J Geskin; Patrizia Fuschiotti
Journal:  Clin Cancer Res       Date:  2022-06-13       Impact factor: 13.801

9.  Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Ivan V Litvinov; Simon Fredholm; David L Petersen; Claudia Nastasi; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Lars Iversen; Mogens Kilian; Sergei B Koralov; Niels Odum
Journal:  Blood       Date:  2016-01-05       Impact factor: 22.113

10.  Cutaneous T-Cell Lymphoma Skin Microbiome Is Characterized by Shifts in Certain Commensal Bacteria but not Viruses when Compared with Healthy Controls.

Authors:  Catriona P Harkins; Margaret A MacGibeny; Katherine Thompson; Bianka Bubic; Xin Huang; Isabelle Brown; Jin Park; Jay-Hyun Jo; Julia A Segre; Heidi H Kong; Sima Rozati
Journal:  J Invest Dermatol       Date:  2020-11-16       Impact factor: 7.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.